Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway

Journal of the Neurological Sciences

Volumn 310, Issue 1-2, 2011, Pages 40-43

  Booij, Jan ^a   Berendse, Henk W ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dopamine; Parkinson's disease; PET; Progression; SPECT

Indexed keywords

6 FLUORODOPA F 18; DOPA; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LEVODOPA; NEURTURIN; PLACEBO; PRAMIPEXOLE; ROPINIROLE;

ARTICLE; BRAIN DEPTH STIMULATION; DISEASE COURSE; DOPAMINERGIC SYSTEM; DRUG UPTAKE; FOLLOW UP; HUMAN; NEUROIMAGING; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; ANTIPARKINSON AGENTS; CORPUS STRIATUM; DISEASE PROGRESSION; DOPAMINE; HUMANS; PARKINSON DISEASE; RADIOPHARMACEUTICALS; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 80054101859     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.07.029     Document Type: Article

References (41)

1. J. Booij, G. Tissingh, A. Winogrodzka, and E.A. van Royen Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism [review] Eur J Nucl Med 26 1999 171 182 (Pubitemid 29140031)
2. O.T. Dejesus, C.J. Endres, S.E. Shelton, R.J. Nickles, and J.E. Holden Noninvasive assessment of aromatic l-amino acid decarboxylase activity in aging rhesus monkey brain in vivo Synapse 39 2001 58 63
3. C.S. Lee, A. Samii, V. Sossi, T.J. Ruth, M. Schulzer, and J.E. Holden In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease Ann Neurol 47 2000 493 503 (Pubitemid 30194606)
4. K.J. Lin, Y.H. Weng, S.P. Wey, I.T. Hsiao, C.S. Lu, and D. Skovronsky Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent J Nucl Med 51 2010 1480 1485
5. J. Booij, G. Tissingh, G.J. Boer, J.D. Speelman, J.C. Stoof, and A.G.M. Janssen [123I]SPECT shows a pronounced decline of striatal labelling in early and advanced Parkinson's disease J Neurol Neurosurg Psychiatry 62 1997 133 140
6. A. Jucaite, I. Odano, H. Olsson, S. Pauli, and C. Halldin Farde L Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study Eur J Nucl Med Mol Imaging 33 2006 657 668 (Pubitemid 43846756)
7. A. Brück, S. Aalto, E. Rauhala, J. Bergman, R. Marttila, and J.O. Rinne A follow-up study on 6-[18F]fluoro-l-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen Mov Disord 24 2009 1009 1015
8. S. Muramatsu, K. Fujimoto, S. Kato, H. Mizukami, S. Asari, and K. Ikeguchi A phase I study of aromatic l-amino acid decarboxylase gene therapy for Parkinson's disease Mol Ther 18 2010 1731 1735
9. H.W. Berendse, J. Booij, C.M.J.E. Francot, P.L.M. Bergmans, R. Hijman, and J.C. Stoof Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell Ann Neurol 50 2001 34 41 (Pubitemid 32591460)
10. M.M. Ponsen, D. Stoffers, J. Booij, B.L.F. van Eck-Smit, E.Ch. Wolters, and H.W. Berendse Idiopathic hyposmia as a preclinical sign of Parkinson's disease Ann Neurol 56 2004 173 181 (Pubitemid 39037913)
11. M.M. Ponsen, D. Stoffers, E.Ch. Wolters, J. Booij, and H.W. Berendse Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease J Neurol Neurosurg Psychiatry 81 2010 396 399
12. P. Piccini, D.J. Burn, R. Ceravolo, D. Maraganore, and D.J. Brooks The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins Ann Neurol 45 1999 577 582 (Pubitemid 29217585)
13. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 1991 2283 2301
14. F.J. Vingerhoets, B.J. Snow, C.S. Lee, M. Schulzer, E. Mak, and D.B. Calne Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism Ann Neurol 36 1994 759 764
15. P.K. Morrish, G.V. Sawle, and D.J. Brooks An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease Brain 119 1996 585 591
16. P.K. Morrish, J.S. Rakshi, D.L. Bailey, G.V. Sawle, and D.J. Brooks Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET J Neurol Neurosurg Psychiatry 64 1998 314 319
17. K. Marek, R. Innis, C. van Dyck, B. Fussell, M. Early, and S. Eberly [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression Neurology 57 2001 2089 2094 (Pubitemid 33126879)
18. W. Pirker, S. Djamshidian, S. Asenbaum, W. Gerschlager, G. Tribl, and M. Hoffmann Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study Mov Disord 17 2002 45 53 (Pubitemid 36041259)
19. A. Winogrodzka, P. Bergmans, J. Booij, E.A. van Royen, J.C. Stoof, and E.Ch. Wolters [123I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease J Neurol Neurosurg Psychiatry 74 2003 294 298 (Pubitemid 36259350)
20. J.R. Adams, H. van Netten, M. Schulzer, E. Mak, J. Mckenzie, and A. Strongosky PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation Brain 128 2005 2777 2785 (Pubitemid 41746632)
21. J. Booij, J.B. Habraken, P. Bergmans, G. Tissingh, A. Winogrodzka, and E.C. Wolters Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease J Nucl Med 39 1998 1879 1884 (Pubitemid 28518886)
22. F.J. Vingerhoets, M. Schulzer, T.J. Ruth, J.E. Holden, and B.J. Snow Reproducibility and discriminating ability of fluorine-18-6-fluoro-l-Dopa PET in Parkinson's disease J Nucl Med 37 1996 421 426
23. J. Booij, and P. Kemp Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs Eur J Nucl Med Mol Imaging 35 2008 424 438
24. D.P. Eisenberg, P.D. Kohn, E.B. Baller, J.A. Bronstein, J.C. Masdeu, and K.F. Berman Seasonal effects on human striatal presynaptic dopamine synthesis Neuroscience 30 2010 14691 14694
25. S. Fahn, D. Oakes, I. Shoulson, K. Kieburtz, A. Rudolph, and A. Lang Levodopa and the progression of Parkinson's disease N Engl J Med 351 2004 2498 2508
26. N. Pavese, L. Kiferle, and P. Piccini Neuroprotection and imaging studies in Parkinson's disease Parkinsonism Relat Disord 15 2009 S33 S37
27. Parkinson Study Group Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression JAMA 287 2002 1653 1661
28. A.L. Whone, R.L. Watts, A.J. Stoessl, M. Davis, S. Reske, and C. Nahmias Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study Ann Neurol 54 2003 93 101 (Pubitemid 36764985)
29. W.H. Oertel, J. Schwarz, and K.L. Leenders Pelmopet Study Group. Results of a 3-year randomized, double blind, PET controlled study of pergolide vs levodopa as monotherapy in early Parkinson's disease (PELMOPET-trial) J Neurosci 187 2001 444
30. R. Hilker, A.T. Portman, J. Voges, M.J. Staal, L. Burghaus, and T. van Laar Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation J Neurol Neurosurg Psychiatry 76 2005 1217 1221 (Pubitemid 41208371)
31. A. Lokkegaard, L.M. Werdelin, L. Regeur, M. Karlsborg, S.R. Jensen, and E. Brødsgaard Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson's disease Eur J Nucl Med Mol Imaging 34 2007 508 516 (Pubitemid 46426985)
32. S.S. Gill, N.K. Patel, G.R. Hotton, K. O'Sullivan, R. McCarter, and M. Bunnage Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat Med 9 2003 589 595 (Pubitemid 36597106)
33. A.E. Lang, S. Gill, N.K. Patel, A. Lozano, J.G. Nutt, and R. Penn Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease Ann Neurol 59 2006 459 466 (Pubitemid 43358066)
34. W.J. Marks Jr., J.L. Ostrem, L. Verhagen, P.A. Starr, P.S. Larson, and R.A. Bakay Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial Lancet Neurol 7 2008 400 408
35. W.J. Marks Jr., R.T. Bartus, J. Siffert, C.S. Davis, A. Lozano, and N. Boulis Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial Lancet Neurol 9 2010 1164 1172
36. C.W. Christine, P.A. Starr, P.S. Larson, J.L. Eberling, W.J. Jagust, and R.A. Hawkins Safety and tolerability of putaminal AADC gene therapy for Parkinson disease Neurology 73 2009 1662 1669
37. C.W. Olanow, C.G. Goetz, J.H. Kordower, A.J. Stoessl, V. Sossi, and M.F. Brin A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Ann Neurol 54 2003 403 414 (Pubitemid 37072046)
38. Y. Ma, C. Tang, T. Chaly, P. Greene, R. Breeze, and S. Fahn Dopamine cell implantation in Parkinson's disease: long-term clinical and 18F-FDOPA PET outcomes J Nucl Med 51 2010 7 15
39. V. Cochen, M.J. Ribeiro, J.P. Nguyen, J.M. Gurruchaga, G. Villafane, and C. Loc'h Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue Mov Disord 18 2003 928 932 (Pubitemid 37021169)
40. O. Pogarell, W. Koch, F.J. Gildehaus, A. Kupsch, O. Lindvall, and W.H. Oertel Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts Eur J Nucl Med Mol Imaging 33 2006 407 411
41. S. Love, P. Plaha, N.K. Patel, G.R. Hotton, D.J. Brooks, and S.S. Gill Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain Nat Med 11 2005 703 704 (Pubitemid 41021193)